CONTINUE TO SITE

OR WAIT null SECS

(Sponsored) Taar1 Agonism: A Novel Approach to Treating Schizophrenia2021 NEI CongressAACAP Annual Meeting Highlights: October 18-30ADHDCase Reviews in Bipolar Disorder: Around The PracticeEvolving Management Strategies for Treatment-Resistant DepressionMajor Depressive DisorderManaging Patients With Treatment Resistant DepressionManaging Tardive DyskinesiaNewport AcademyPatient Cases in NarcolepsySchizophreniaSleep Disorders

Commentary

Couch In CrisisEarly Career PsychiatryHistory of PsychiatryResidents Corner

Cultural Corner

Film and Book ReviewsPoetryWriters Contest

Psychiatric Practice

BurnoutCareersCodingGuidelinesRisk ManagementTelepsychiatry

Series

Climate ChangeCritical Conversations in PsychiatryPortraitsPsychiatric Views on the Daily NewsTales From the Clinic: The Art of PsychiatryTales from the New Asylum

Topics

All TopicsAddiction & Substance UseAnxiety & Stress DisordersBipolar DisorderCase DiscussionsDepressionForensic PsychiatryNeuropsychiatryPersonality DisordersPsychosomaticsSchizophrenia/PsychosisSex & SexualitySleep DisordersSuicide

Media

Around the PracticeBetween the LinesPsychViewCase-Based Psych PerspectivesMedical World NewsPsychPearls PodcastSlideshowsVideosViewpoints

Publications

Psychiatric TimesAll PublicationsPartner Perspectives

Job Board CME/CE Partners

Resources

Clinical ScalesConference CoverageConference ListingInteractive ToolsQ&AQuizzesSpecial ReportsSponsoredTipsheetsToolkits

eNewsletterPrint Subscription

Contact Us
Editorial
Terms and Conditions
Privacy Policy
Do Not Sell My Personal Information

SpotlightSee All >

(Sponsored) Taar1 Agonism: A Novel Approach to Treating Schizophrenia
2021 NEI Congress
AACAP Annual Meeting Highlights: October 18-30
ADHD
Case Reviews in Bipolar Disorder: Around The Practice
Evolving Management Strategies for Treatment-Resistant Depression
Major Depressive Disorder
Managing Patients With Treatment Resistant Depression
Managing Tardive Dyskinesia
Newport Academy
Patient Cases in Narcolepsy
Schizophrenia
Sleep Disorders

CommentarySee All >

Couch In Crisis
Early Career Psychiatry
History of Psychiatry
Residents Corner

Cultural CornerSee All >

Film and Book Reviews
Poetry
Writers Contest

Psychiatric PracticeSee All >

Burnout
Careers
Coding
Guidelines
Risk Management
Telepsychiatry

SeriesSee All >

Climate Change
Critical Conversations in Psychiatry
Portraits
Psychiatric Views on the Daily News
Tales From the Clinic: The Art of Psychiatry
Tales from the New Asylum

Contact Us
Editorial
Terms and Conditions
Privacy Policy
Do Not Sell My Personal Information

Frank Chen, MD

home

Articles

Long-Acting Injectable Antipsychotics in the Era of COVID-19

November 19, 2020

Video

COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.